"IPIX is working on one or more collaborations that will bring shareholders a great return on today's prices."
Don't misunderstand me. You're absolutely entitled to hold and express that belief based on the Company's public statements which say exactly that.
It's this bullshit that I find misleading and deceptive, because you don't know it to be true and the Company itself hasn't said so for almost 8 weeks.:
"The term sheet is alive and well."
We're free to express our opinions here. But they should be stated as opinions....you know the difference.
Maybe this suggests something about the Company's real expectations about this latest non-binding term sheet. The press release that announced it was only 4 paragraphs long including the headline:
Innovation Pharmaceuticals Announces Non-Binding Term Sheet Signed with Global Pharmaceutical Company to Develop and Commercialize Brilacidin for the Treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis
BEVERLY, MA – May 16, 2019 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that the Company has signed a non-binding term sheet with a global pharmaceutical company to develop and commercialize locally-administered Brilacidin (e.g., foam, enema, gel), on a worldwide basis, for the treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis.
The non-binding term sheet also includes a Right of First Refusal for rights to Brilacidin for the treatment of more extensive forms of Inflammatory Bowel Disease, such as Ulcerative Colitis and Crohn’s Disease, and a Right of First Negotiation for rights to Brilacidin in other Gastrointestinal (GI) indications.
Completion of the transaction, as specified in the non-binding term sheet, is subject to further negotiation and execution of a definitive agreement. If the definitive agreement is reached and signed, the Company anticipates that it would receive an upfront payment, plus potential additional regulatory and commercial milestone payments, as well as royalties.
-----------------------------------
Give it a fresh read...it's just 4 short paragraphs. Take note of the descriptive phrase that the Company decided to repeat in each and every one of them. Did you see it?
It's a phrase that would satisfy any legal concerns by using it once. Most of the investment community is smart enough to not need a critical phrase repeated 3 times before they "get it". Was IPIX at a loss for other words that day?
"No money to be found in the rearview mirror."
Really? Because many here have left some behind.
Market Data 
Markets 
AI
